chromatography
Bio-Rad Laboratories Q2 Revenues Decline 6 Percent, Firm Lowers Full-Year Outlook
Bio-Rad is expecting a decline in revenues for the full year due to a slower pace of recovery among customers of its core businesses.
The company's nucleic acid extraction kits have offered labs relief from COVID-19-related shortages of traditional silica-based bind-wash-elute assays.
Roche SARS-CoV-2 Lateral Flow Antigen Test Could Meet Significant Demand
If the lateral flow assay receives US regulatory approval, it would be the first antigen test for use in both symptomatic and asymptomatic individuals.
Roche Expects CE Mark for SARS-CoV-2 Rapid Antigen Test
The point-of-care test provides results in 15 minutes and can be used for both symptomatic and asymptomatic patients.
Visceral Leishmaniasis Tests Lack Accuracy, Study Finds
The study compared a variety of serological tests for visceral leishmaniasis that are available in Brazil, a hotspot for the parasitic disease.
Feb 25, 2019
Danaher to Buy GE Biopharma for $21.4B
Feb 20, 2019
Agilent Q1 Revenues Up 6 Percent
May 8, 2018